- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare LIC MF Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 1.0 | 4.0 |
Min SIP Amount | ₹200 | ₹500 |
Expense Ratio | 2.45 | 1.94 |
NAV | ₹28.65 | ₹413.22 |
Fund Started | 08 Feb 2019 | 04 Jun 1999 |
Fund Size | ₹86.26 Cr | ₹3628.03 Cr |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
1.0
4.0
Min SIP Amount
₹200
₹500
Expense Ratio
2.45
1.94
NAV
₹28.65
₹413.22
Fund Started
08 Feb 2019
04 Jun 1999
Fund Size
₹86.26 Cr
₹3628.03 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 28.12% | 28.28% |
3 Year | 17.70% | 23.63% |
5 Year | 21.27% | 27.30% |
1 Year
28.12%
28.28%
3 Year
17.70%
23.63%
5 Year
21.27%
27.30%
Holding Analysis
Equity | 97.00% | 96.55% |
Cash | 3.00% | 3.37% |
Equity
97.00%
96.55%
Cash
3.00%
3.37%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.46% |
Piramal Pharma Ltd. | 7.02% |
Artemis Medicare Services Ltd. | 6.22% |
Torrent Pharmaceuticals Ltd. | 5.28% |
Glenmark Pharmaceuticals Ltd. | 4.59% |
Mankind Pharma Ltd. | 4.51% |
Cipla Ltd. | 4.33% |
Ipca Laboratories Ltd. | 4.21% |
JB Chemicals & Pharmaceuticals Ltd. | 4.14% |
Abbott India Ltd. | 4.12% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.00% |
Max Healthcare Institute Ltd. | 6.22% |
Divi's Laboratories Ltd. | 6.05% |
Cipla Ltd. | 5.90% |
Lupin Ltd. | 5.19% |
Lonza Group Ag | 4.16% |
Mankind Pharma Ltd. | 4.15% |
Poly Medicure Ltd. | 3.60% |
Krishna Institute of Medical Sciences Ltd | 3.46% |
Jupiter Life Line Hospitals Ltd. | 3.45% |
Fund Manager
Name | Karan Doshi | Tanmaya Desai |
Start Date | 31 Jul 2023 | 27 Jun 2011 |
Name
Karan Doshi
Tanmaya Desai
Start Date
31 Jul 2023
27 Jun 2011
About Fund
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 08 Feb 2019 | 04 Jun 1999 |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Feb 2019
04 Jun 1999
